ATAI

AtaiBeckley Inc.

Healthcare · Biotechnology

$69.39 sample

+0.43 (+0.62%) 1D

Market cap

$127.0B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-04

Alerts

8

Price$69.39 +4.30% 3M daily closessample

70.1865.00

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider sell: Chief Financial Officer
Oct 05INSInsider sell: Chief Financial Officer
Sep 24INSInsider sell: Chief Executive Officer
Sep 18INSInsider sell: Chief Executive Officer
Sep 10INSInsider sell: 10% owner
Sep 04SECForm 144 filed
Aug 31INSInsider sell: Director
Aug 26SECForm 144 filed

Sign up to see the real ATAI record →

Company facts

SEC EDGAR registration

Name: AtaiBeckley Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +1sample, -100 to +100
Reporting currency: USD

Who is positioning in ATAI

sample

Insiders: 16 insider transactions over 90 days, net selling, $282.9M
Congress: No member trades over 90 days
Institutions · 13F: 28 funds hold $2.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$6.4B +25.1% y/y

Q4 2024Q3 2026

Inventory$3.8B +19.7% y/y

Q4 2024Q3 2026

Accounts receivable$2.8B +7.8% y/y

Q4 2024Q3 2026

Total debt$7.3B +14.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $121.0B -5.9% 3M
Sample peer B: $32.7B +2.0% 3M
Sample peer C: $67.0B -10.1% 3M
Sample peer D: $57.7B -8.4% 3M
Sample peer E: $122.3B -7.8% 3M